Sequence Similarity Clusters for the Entities in PDB 1TJH

Entity #1 | Chains: L
anti-HIV-1 antibody 2F5 Light Chain protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 7 10393
95 % 3 41 1277
90 % 186 701 3
70 % 639 2287 1
50 % 1311 4633 1
40 % 1311 4633 1
30 % 1465 5461 1
Entity #2 | Chains: H
anti-HIV-1 antibody 2F5 Heavy Chain protein, length: 237 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 4 20482
95 % 3 41 1274 Flexibility: Low
Max RMSD: 1.8, Avg RMSD: 0.6
PDBFlex
90 % 3 41 1302
70 % 632 2244 2
50 % 1312 4633 1
40 % 1312 4633 1
30 % 1466 5461 1
Entity #3 | Chains: P
Envelope glycoprotein GP41 protein, length: 13 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5UD9 1 H Fab heavy chain 9606
17 5UD9 2 L Light chain 9606
18 4P48 1 A Antibody scFv 180 9031
19 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
20 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
21 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
22 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
23 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
24 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
25 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
26 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
27 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
28 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
29 4XCF 1 L 4E10 Fab light chain 9606
30 4XCF 2 H 4E10 Fab heavy chain 9606
31 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
32 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
33 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
34 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
35 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
36 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
37 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
38 5X08 1 H Fab 4E10 Heavy chain 9606
39 5X08 2 L Fab 4E10 Light chain 9606
40 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
41 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
42 4XAW 1 L 4E10 Fab light chain 9606
43 4XAW 2 H 4E10 Fab heavy chain 9606
44 4P49 1 A Antibody scFv B8 9031
45 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
46 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
47 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
48 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
49 2NW2 1 A ELS4 TCR alpha chain 9606
50 2NW2 2 B ELS4 TCR beta chain 9606
51 2VXV 1 H HUMAN IGG ABT-325 9606
52 2VXV 2 L HUMAN IGG ABT-325 9606
53 4GXV 1 H, I Antibody 1F1, heavy chain 9606
54 4GXV 2 L, M Antibody 1F1, light chain 9606
55 2VXT 1 H MURINE IGG 125-2H 10090
56 2VXT 3 L MURINE IGG 125-2H 10090
57 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
58 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
59 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
60 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
61 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
62 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
63 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
64 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
65 4HPY 1 H CH59 Fab heavy chain 9606
66 4HPY 2 L CH59 Fab light chain 9606
67 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
68 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
69 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
70 4JG1 1 L Fab light chain 9606
71 4JG1 2 H Fab heavy chain 9606
72 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
73 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
74 5I8C 1 A VRC34.01 Fab heavy chain 9606
75 5I8C 2 B VRC34.01 Fab light chain 9606
76 4O5L 1 L Fab F045-092 light chain 9606
77 4O5L 2 H Fab F045-092 heavy chain 9606
78 5MYX 1 A, C Fab c#24 light chain 10090
79 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
80 3IFL 1 L 12A11 FAB antibody light chain 10090
81 3IFL 2 H 12A11 FAB antibody heavy chain 10090
82 3PP4 1 H GA101 Fab heavy chain 10090
83 3PP4 2 L GA101 Fab light chain 10090
84 3KDM 1 A, L Immunoglobulin light chain 9606
85 3KDM 2 B, H Immunoglobulin heavy chain 9606
86 5NIV 1 A Light chain of 5D3 Fab 10090
87 5NIV 2 B Heavy chain of 5D3 Fab 10090
88 5N4J 1 L LIGHT CHAIN 9606
89 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
90 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
91 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
92 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
93 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
94 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
95 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
96 4PTU 1 A Antibody pn132p2C05, light chain 9606
97 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
98 4TPR 1 L If kappa light chain 10090
99 4TPR 2 H Fab heavy chain 10090
100 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
101 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
102 3IFN 1 H 12A11 FAB antibody heavy chain 10090
103 3IFN 2 L 12A11 FAB antibody light chain 10090
104 5U3P 1 H DH511.4 Fab Heavy Chain 9606
105 5U3P 2 L DH511.4 Fab Light Chain 9606
106 4TOY 1 H 35O22 Fab Heavy chain 9606
107 4TOY 2 L 35O22 Fab Light chain 9606
108 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
109 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
110 3NPS 2 B S4 FAB HEAVY CHAIN 9606
111 3NPS 3 C S4 FAB LIGHT CHAIN 9606
112 5I4F 1 A scFv 2D10 10090
113 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
114 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
115 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
116 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
117 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
118 4XC3 1 L 4E10 Fab light chain 9606
119 4XC3 2 H 4E10 Fab heavy chain 9606
120 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
121 4M5Y 1 H, I Fab 5J8 heavy chain 9606
122 4M5Y 2 L, M Fab 5J8 light chain 9606
123 4TQE 1 L If kappa light chain 10090
124 4TQE 2 H Fab heavy chain 10090
125 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
126 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
127 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
128 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
129 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
130 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
131 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
132 5VSI 2 L CH1/Ckappa Fab light chain 9606
133 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
134 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
135 5JXA 1 H VRC03 Heavy chain 9606
136 5JXA 2 L VRC03 Light chain 9606
137 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
138 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
139 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
140 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
141 3NTC 1 L Fab light chain 10090
142 3NTC 2 H Fab heavy chain 10090
143 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
144 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
145 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
146 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
147 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
148 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
149 4NWU 1 H APE1551 Ab Fab heavy chain 9606
150 4NWU 2 L APE1551 Ab Fab light chain 9606
151 1KGC 1 D T-cell receptor alpha chain 9606
152 1KGC 2 E T-cell receptor beta chain 9606
153 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
154 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
155 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
156 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
157 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
158 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
159 5EWI 1 H VRC38.01 Heavy Chain 9606
160 5EWI 2 L VRC38.01 Light Chain 9606
161 5E2W 1 L AT8 LIGHT CHAIN 10090
162 5E2W 2 H AT8 HEAVY CHAIN 10090
163 5MYK 1 A Fab c#17 light chain 10090
164 5MYK 2 B Fab c#17 heavy chain 10090
165 4NZR 1 H PGT135 heavy chain Fab 9606
166 4NZR 2 L PGT135 light chain Fab 9606
167 5MYO 1 A, C Fab c#6 light chain 10090
168 5MYO 2 B, D Fab c#6 heavy chain 10090
169 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
170 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
171 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
172 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
173 5UEL 1 H 354NC102 Fab Heavy Chain 9606
174 5UEL 2 L 354NC102 Fab Light Chain 9606
175 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
176 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
177 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
178 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
179 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
180 5E2V 1 L AT8 LIGHT CHAIN 10090
181 5E2V 2 H AT8 HEAVY CHAIN 10090
182 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
183 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
184 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
185 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
186 5JUE 1 L light chain of UIC2 Fab 10090
187 5JUE 2 H heavy chain of UIC2 Fab 10090
188 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
189 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
190 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
191 5JR1 1 H 10E8 heavy chain 9606
192 5JR1 2 L 10E8 mature light chain 9606
193 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
194 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
195 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
196 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
197 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
198 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
199 5I66 1 A 8B6 antibody, heavy chain 10090
200 5I66 2 B 8B6 antibody, light chain 10090
201 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
202 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
203 3QQ9 1 C, L 101F LIGHT CHAIN 10090
204 3QQ9 2 D, H 101F HEAVY CHAIN 10090
205 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
206 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
207 5I1K 1 L FAB LIGHT CHAIN 9606
208 5I1K 2 H FAB HEAVY CHAIN 9606
209 3OZ9 1 L Fab NC-1 kappa light chain 10090
210 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
211 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
212 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
213 5V7U 1 L CBTAU-22.1 Fab light chain 9606
214 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
215 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
216 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
217 3G5Y 1 A 175 light chain 10090
218 3G5Y 2 B 175 heavy chain 10090
219 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
220 4N8C 2 L, M Light chain of monoclonal antibody 10090
221 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
222 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
223 4HGW 1 A Antibody Fab fragment, light chain 10090
224 4HGW 2 B Antibody Fab fragment, heavy chain 10090
225 1NLB 1 L antibody 19D9D6 light chain 10090
226 1NLB 2 H antibody 19D9D6 heavy chain 10090
227 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
228 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
229 3VFG 1 L 3F8 Light Chain 10090
230 3VFG 2 H 3F8 Heavy Chain 10090
231 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
232 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
233 3QRG 1 L Fab light chain 9606
234 3QRG 2 H Fab heavy chain Fd fragment 9606
235 4LLY 2 B, D light chain Clambda 9606
236 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
237 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
238 5EZI 1 H Fab c12 heavy chain 9606
239 5EZI 2 L Fab c12 Light chain 9606
240 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
241 4K23 1 H anti-uPAR antibody, heavy chain 10090
242 4K23 2 L anti-uPAR antibody, light chain 10090
243 3NCJ 1 L Fab15 Mut8 light chain 9606
244 3NCJ 2 H Fab15 Mut8 heavy chain 9606
245 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
246 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
247 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
248 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
249 5W05 1 L M59 FAB LIGHT CHAIN 10090
250 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
251 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
252 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
253 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
254 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
255 4M61 1 A, C Fab A52 light chain 10090
256 4M61 2 B, D Fab A52 heavy chain 10090
257 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
258 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
259 1UM5 1 L Antibody 21H3 L chain 10090
260 1UM5 2 H Antibody 21H3 H chain 10090
261 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
262 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
263 4NWT 1 L APE1531 Ab Fab light chain 9606
264 4NWT 2 H APE1531 Ab Fab heavy chain 9606
265 3WHX 1 A mAb Fab H fragment 10090
266 3WHX 2 B mAb Fab L fragment 10090
267 3NA9 1 L Fab15 light chain 9606
268 3NA9 2 H Fab15 heavy chain 9606
269 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
270 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
271 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
272 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
273 4LRI 1 A, B MSL-109 Light Chain 9606
274 4LRI 2 C, P MSL-109 Heavy Chain 9606
275 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
276 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
277 4JN2 1 A, L anti dabigatran Fab 10090
278 4JN2 2 B, H anti dabigatran Fab 10090
279 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
280 4XBE 2 H 4E10 Fab heavy chain 9606
281 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
282 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
283 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
284 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
285 4JFZ 1 L Fab light chain 9606
286 4JFZ 2 H Fab heavy chain 9606
287 3WIF 1 A mAb Fab H fragment 10090
288 3WIF 2 B mAb Fab L fragment 10090
289 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
290 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
291 3MBX 1 L X836 LIGHT CHAIN 10090
292 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
293 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
294 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
295 4HHA 1 A Fab KE5 Fab fragment KE5 9606
296 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
297 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
298 4RGO 2 H 14G8 heavy chain Fab 10090
299 4RGO 3 L 14G8 light chain Fab 10090
300 5GRY 1 A, G diabody 9606
301 3NAA 1 L Fab15 Mut5 light chain 9606
302 3NAA 2 H Fab15 Mut5 heavy chain 9606
303 1Q0X 1 L Fab 9B1, light chain 10090
304 1Q0X 2 H Fab 9B1, heavy chain 10090
305 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
306 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
307 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
308 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
309 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
310 5IK3 2 B, D 1E03 Fab fragment light chain 9606
311 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
312 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
313 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
314 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
315 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
316 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
317 4WUK 1 H CH65 heavy chain 9606
318 4WUK 2 L CH65 light chain 9606
319 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
320 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
321 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
322 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
323 5JOP 1 D, L Fab 14.22 light chain 10090
324 5JOP 2 E, H Fab14.22 heavy chain 10090
325 4HPO 1 H CH58 Fab heavy chain 9606
326 4HPO 2 L CH58 Fab light chain 9606
327 5IT2 1 H heavy chain 9606
328 5IT2 2 L light chain 9606
329 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
330 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
331 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
332 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
333 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
334 2W59 1 A, B IGY FCU3-4 9031
335 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
336 5GZ0 1 A, C FM329 light chain 1383439
337 5GZ0 2 B, D FM329 heavy chain 1383439
338 4PUB 1 H DX-2930 HEAVY CHAIN 9606
339 4PUB 2 L DX-2930 LIGHT CHAIN 9606
340 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
341 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
342 5TEZ 4 I TCR F50 alpha chain 9606
343 5TEZ 5 J TCR F50 beta chain 9606
344 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
345 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
346 5GS3 1 A, H diabody protein 9606
347 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
348 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
349 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
350 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
351 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
352 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
353 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
354 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
355 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
356 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
357 3UYR 1 H antibody Fab heavy chain 10090
358 3UYR 2 L antibody Fab light chain 10090
359 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
360 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
361 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
362 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
363 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
364 3OAZ 2 K, L Fab 2G12, light chain 9606
365 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
366 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
367 1ZAN 1 L Fab AD11 Light Chain 10116
368 1ZAN 2 H Fab AD11 Heavy Chain 10116
369 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
370 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
371 4N0Y 1 H IGH526 Heavy Chain 9606
372 4N0Y 2 L IGH526 Light Chain 9606
373 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
374 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
375 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
376 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
377 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
378 1RZF 1 L Fab E51 light chain 9606
379 1RZF 2 H Fab E51 heavy chain 9606
380 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
381 4KTE 2 L GE148 Light Chain Fab 9544
382 5I8O 1 H HMM5 antibody heavy chain 9606
383 5I8O 2 L HMM5 antibody light chain 9606
384 4OUO 1 A anti Bla g 1 scFv 9031
385 4JG0 1 L Fab light chain 9606
386 4JG0 2 H Fab heavy chain 9606
387 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
388 4YGV 2 B, L aDabi-Fab2a light chain 9606
389 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
390 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
391 3EO0 1 A, C GC-1008 Fab Light Chain 10090
392 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
393 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
394 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
395 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
396 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
397 4FQI 3 H antibody CR9114 heavy chain Fab 9606
398 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
399 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
400 4JHA 2 L D25 light chain 9606
401 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
402 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
403 4PTT 1 A Antibody pn132p2C05, light chain 9606
404 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
405 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
406 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
407 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
408 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
409 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
410 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
411 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
412 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
413 4DGV 1 H HCV1 Heavy Chain Fab 9606
414 4DGV 2 L HCV1 Light Chain 9606
415 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
416 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
417 5TH2 1 A, C cetuximab Fab, light chain 10090
418 5TH2 2 B, D cetuximab Fab, heavy chain 10090
419 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
420 5I8K 1 L HHH1 Fab Light chain 9606
421 5I8K 2 H HHH1 Fab Heavy chain 9606
422 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
423 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
424 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
425 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
426 1YNL 1 L Ig gamma light chain 10090
427 1YNL 2 H Ig gamma heavy chain 10090
428 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
429 5EPM 2 B, F Antibody Fab fragment light chain 10090
430 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
431 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
432 5VH5 1 A Infliximab Fc 10090
433 3UMT 1 A scFv heavy chain and light chain 10090
434 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
435 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
436 4NUJ 1 A PGT152 light chain 9606
437 4NUJ 2 B PGT152 heavy chain 9606
438 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
439 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
440 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
441 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
442 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
443 3U2S 2 B, L PG9 light chain 9606
444 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
445 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
446 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
447 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
448 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
449 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
450 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
451 4NUG 1 L PGT151 light chain 9606
452 4NUG 2 H PGT151 heavy chain 9606
453 3IU4 1 H chP3 Fab heavy chain 10090
454 3IU4 2 L chP3 Fab light chain 10090
455 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
456 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
457 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
458 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
459 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
460 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
461 1P7K 1 A, L antibody light chain FAB 10090
462 1P7K 2 B, H antibody heavy chain FAB 10090
463 3RVV 2 C 4C1 - light chain 10090
464 3RVV 3 D 4C1 - heavy chain 10090
465 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
466 3P0Y 2 H Fab DL11 heavy chain 9606
467 3P0Y 3 L Fab DL11 light chain 9606
468 4NPY 1 A, L germline PGT121 light chain Fab 9606
469 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
470 5IBU 1 B, L 6652 Light Chain 9606
471 5IBU 2 G, H 6652 Heavy Chain 9606
472 5VPL 2 C 4C1 - LIGHT CHAIN 10090
473 5VPL 3 D 4C1 - HEAVY CHAIN 10090
474 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
475 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
476 2YPV 2 H FAB 12C1 10090
477 2YPV 3 L FAB 12C1 10090
478 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
479 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
480 4JY5 1 L PGT122 light chain Fab 9606
481 4JY5 2 H PGT122 heavy chain Fab 9606
482 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606
483 3NAC 1 L Fab15 Mut7 light chain 9606
484 3NAC 2 H Fab15 Mut7 heavy chain 9606
485 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
486 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
487 1Q72 1 L Fab M82G2, Light chain 10090
488 1Q72 2 H Fab M82G2, Heavy chain 10090
489 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
490 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
491 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
492 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
493 4YHO 1 H aDabi-Fab3 heavy chain 9606
494 4YHO 2 L aDabi-Fab3 light chain 9606
495 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
496 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
497 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
498 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
499 4DGY 1 H HCV1 Heavy Chain Fab 9606
500 4DGY 2 L HCV1 Light Chain 9606
501 5EN2 1 A GD01 heavy chain 10090
502 5EN2 2 B GD01 light chain 10090
503 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
504 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
505 3MXW 2 L 5E1 light chain 9606
506 3MXW 3 H 5E1 heavy chain 9606
507 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
508 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
509 3EO9 1 L Efalizumab Fab fragment, light chain 9606
510 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
511 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
512 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
513 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
514 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
515 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
516 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
517 5WUV 1 L light chain 9606
518 5WUV 2 H heavy chain 9606
519 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
520 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
521 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
522 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
523 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
524 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
525 4JM4 1 H PGT 135 Heavy Chain Fab 9606
526 4JM4 2 L PGT 135 Light Chain Fab 9606
527 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
528 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
529 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
530 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
531 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
532 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
533 4WNQ 1 A, C TCR Variable Delta 1 chain and TCR constant Alpha chain 9606
534 4WNQ 2 B, D TCR Variable Beta 2 (TRBV20) chain and TCR constant Beta chain 9606
535 2Q86 2 B, D Vbeta8.2 extracellular domain 10090
536 5TPP 1 L DH270.5 Fab heavy chain 9606
537 5TPP 2 H DH270.5 Fab light chain 9606
538 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
539 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
540 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
541 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
542 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
543 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
544 5D7K 1 D MAV36 TCR Alpha Chain 9606
545 5D7K 2 E MAV36 TCR Beta Chain 9606
546 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
547 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
548 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
549 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
550 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
551 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
552 5TL5 1 L M2177 LIGHT CHAIN 10090
553 5TL5 2 H M2177 HEAVY CHAIN 10090
554 2FX7 1 L Fab 4E10 Light Chain 9606
555 2FX7 2 H Fab 4E10 Heavy Chain 9606
556 5W5N 1 A, B Immunoglobulin heavy constant gamma 4 Sigma2 Fc fragment, UNP residues 106-327 9606
557 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
558 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
559 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
560 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
561 3WFH 1 A mAb Fab H fragment 10090
562 3WFH 2 B mAb Fab L fragment 10090
563 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
564 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
565 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
566 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
567 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
568 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
569 5HYF 1 A Ig gamma-1 chain C region Knob protein UNP residues 104-330 9606
570 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
571 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
572 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
573 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
574 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
575 5HI4 3 D, L CAT-2000 FAB light chain 9606
576 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
577 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
578 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
579 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
580 3RVW 2 C 4C1 - light chain 10090
581 3RVW 3 D 4C1 - heavy chain 10090
582 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
583 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
584 4C54 1 A, B IG GAMMA-4 CHAIN C REGION FC FRAGMENT, RESIDUES 114-327 9606
585 4W4N 1 A, B Ig gamma-1 chain C region UNP residues 107-329 9606
586 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
587 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
588 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
589 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
590 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
591 5HI5 3 D, L CAT-2000 light chain 9606
592 5JO5 1 A, C, E, H 10E8 gHV 9606
593 5JO5 2 B, D, F, L 10E8 gLV 9606
594 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
595 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
596 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
597 5CCK 2 L Antibody 3BC315 Fab light chain 9606
598 3VXS 3 D H27-14 TCR alpha chain 9606
599 3VXS 4 E H27-14 TCR beta chain 9606
600 5I76 1 A, C FM318_light_chain 1383439
601 5I76 2 B, D FM318_heavy_cahin 1383439
602 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
603 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
604 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
605 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
606 5I18 1 L FAB LIGHT CHAIN 9606
607 5I18 2 H FAB HEAVY CHAIN 9606
608 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
609 4JN1 2 L anti-dabigatran Fab1, light chain 10090
610 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
611 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
612 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
613 4G5Z 2 L canakinumab antibody fragment light chain 9606
614 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
615 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
616 2OK0 2 L Fab ED10 light chain 10090
617 2OK0 3 H Fab ED10 heavy chain 10090
618 3SOB 1 L antibody light chain 9606
619 3SOB 3 H antibody heavy chain 9606
620 5AWN 1 H Heavy chain of 3BC176 Fab 9606
621 5AWN 2 L Light chain of 3BC176 Fab 9606
622 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
623 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
624 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
625 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
626 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
627 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
628 5DR5 2 L AbD09097 Fab light chain 9606
629 2IH3 1 A FAB Heavy Chain 10090
630 2IH3 2 B FAB Light Chain 10090
631 2P5E 4 D T-Cell Receptor, Alpha Chain 9606
632 2P5E 5 E Hypothetical protein 9606
633 4KQ3 1 L CNTO3186 light chain Fab 9606
634 4KQ3 2 H CNTO3186 heavy chain Fab 9606
635 4JFX 1 A, L Fab light chain 9606
636 4JFX 2 B, H Fab heavy chain 9606
637 3SGE 1 I, L Light Chain 10090
638 3SGE 2 H, J Heavy Chain 10090
639 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
640 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
641 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
642 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
643 4L4V 3 D, G MAIT T-cell receptor alpha chain 9606
644 4L4V 4 E, H MAIT T-cell receptor beta chain 9606
645 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
646 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
647 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
648 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
649 5FHB 1 H Antibody 100 Fab heavy chain 9606
650 5FHB 2 L Antibody 100 Fab light chain 9606
651 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
652 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
653 1JGU 1 L Antibody Light Chain 10090
654 1JGU 2 H Antibody Heavy Chain 10090
655 4I77 1 H Lebrikizumab heavy chain Fab 9606
656 4I77 2 L Lebrikizumab light chain Fab 9606
657 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
658 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
659 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
660 4O4Y 2 H 2095-2 heavy chain 9986
661 3Q5Y 1 A, B, C, D TCR N15 beta 10090
662 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
663 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
664 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
665 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
666 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
667 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
668 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
669 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
670 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
671 4GLR 3 I, K anti-ptau light chain light chain 9031
672 2VUO 1 A, B IG GAMMA CHAIN C REGION FC FRAGMENT, RESIDUES 229-447 9986
673 4HJG 1 A Trastuzumab light chain 9606
674 4HJG 2 B Trastuzumab heavy chain 9606
675 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
676 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
677 5I30 1 L Fab PL-2 light chain 10090
678 5I30 2 H Fab PL-2 heavy chain 10090
679 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
680 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
681 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
682 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
683 3FN0 1 L Fab Z13e1 light chain 9606
684 3FN0 2 H Fab Z13e1 heavy chain 9606
685 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
686 4YHI 2 B, L aDabi-Fab2a light chain 9606
687 4OSU 1 H SM5-1 Fab Heavy Chain 9606
688 4OSU 2 L SM5-1 Fab Light Chain 9606
689 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
690 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
691 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
692 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
693 5U6Q 2 B, D MAIT T-cell receptor alpha chain 9606
694 5U6Q 3 E, G MAIT T-cell receptor beta chain 9606
695 1T2Q 1 L Fab NNA7 Heavy Chain 10090
696 1T2Q 2 H Fab NNA7 Light Chain 10090
697 5W5M 1 A, B Immunoglobulin heavy constant gamma 4 Sigma1 Fc fragment, UNP residues 106-327 9606
698 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
699 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
700 4MAU 1 L C2244 light chain SEE REMARK 999 10090
701 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
702 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
703 3LEX 2 B, L 11f10 Antibody Light Chain 10090
704 1OP3 1 K, L FAB 2G12, light chain light chain 9606
705 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606
706 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
707 5VH4 2 B, L Infliximab Fab Light Chain 10090
708 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
709 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
710 4PJE 3 E, G TCR-alpha 9606
711 4PJE 4 F, H TCR-beta 9606
712 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
713 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
714 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
715 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
716 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
717 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
718 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
719 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
720 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
721 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
722 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
723 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
724 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
725 3S96 1 A, C 3B5H10 FAB heavy chain 10090
726 3S96 2 B, D 3B5H10 FAB light chain 10090
727 4LKX 1 A Fab fragment heavy chain 9606
728 4LKX 2 B Fab fragment light chain 9606
729 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
730 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
731 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
732 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
733 5JW5 1 A, H MEDI8852 Heavy chain 9606
734 5JW5 2 B, L MEDI8852 Light chain 9606
735 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
736 5VH3 2 B, L Infliximab Fab Light Chain 10090
737 5HDQ 2 H Fab Heavy Chain 10090
738 5HDQ 3 L Fab Light Chain 10090
739 4FQ2 1 H Fab heavy chain 9606
740 4FQ2 2 L Fab light chain 9606
741 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
742 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
743 4MS8 1 C 42F3 alpha 10090
744 4MS8 2 D 42F3 beta 10090
745 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
746 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
747 2A77 1 L Immunoglobulin Light Chain 10090
748 2A77 2 H Immunoglobulin Heavy Chain 10090
749 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
750 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
751 3GO1 1 L Fab 268-D, light chain 9606
752 3GO1 2 H Fab 268-D, heavy chain 9606
753 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
754 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
755 4G9F 4 D beta chain C12C TCR 9606
756 4G9F 5 E beta chain C12C TCR 9606
757 3QWO 1 B, L motavizumab light chain 10090
758 3QWO 2 A, H motavizumab heavy chain 10090
759 3CVI 1 H 25-D1.16 Heavy chain 10090
760 3CVI 2 L 25-D1.16 Light chain 10090
761 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
762 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090
763 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
764 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116
765 4IOI 1 A Trastuzumab light chain 9606
766 4IOI 2 B Trastuzumab heavy chain 9606
767 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
768 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090
769 4OKV 1 A, C heavy chain of 8H7 mAb 10090
770 4OKV 2 B, D light chain of 8H7 mAb 10090
771 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
772 5K8A 2 B, F, H, V Heavy chain 10090
773 1JGV 1 L Antibody Light Chain 10090
774 1JGV 2 H Antibody Heavy Chain 10090
775 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
776 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
777 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090
778 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
779 5GIR 1 A, H Heavy chain of Fab fragment 10090
780 5GIR 2 B, L Light chain of Fab fragment 10090
781 2ADF 2 H 82D6A3 IgG FAB 10090
782 2ADF 3 L 82D6A3 IgG FAB 10090
783 5I16 1 A, L FAB LIGHT CHAIN 9606
784 5I16 2 B, H FAB HEAVY CHAIN 9606
785 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090
786 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090
787 1SVZ 1 A, B single-chain Fv fragment 1696 scFv1696 10090
788 5F9O 2 H CH235.9 Heavy chain 9606
789 5F9O 3 L CH235.09 Light chain 9606
790 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544
791 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544
792 5W5L 1 A, B Immunoglobulin gamma-1 heavy chain Sigma Fc fragment, UNP residues 227-449 9606
793 1UM4 1 L Antibody 21H3 L chain 10090
794 1UM4 2 H Antibody 21H3 H chain 10090
795 4RBP 1 K, L Fab 2G12 light chain 9606
796 4RBP 2 H, M Fab 2G12 heavy chain 9606
797 3I75 1 A Antibody heavy chain 10090
798 3I75 2 B Antibody light chain 10090
799 4XVS 1 H VRC07_1995 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Heavy chain 9606
800 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
801 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606
802 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606
803 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606
804 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
805 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
806 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
807 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090
808 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090
809 5GIS 1 H Heavy chain of Fab fragment 10090
810 5GIS 2 L Light chain of Fab fragment 10090
811 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090
812 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090
813 5FGC 2 B Anti-HCV E2 Fab HC33.8 light chain 9606
814 5FGC 3 E Anti-HCV E2 Fab HC33.8 heavy chain 9606
815 4PJH 3 E, G TCR-alpha 9606
816 4PJH 4 F, H TCR-beta 9606
817 5GRX 1 G, H diabody protein 9606
818 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
819 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
820 5GGQ 1 L nivolumab light chain 9606
821 5GGQ 2 H nivolumab heavy chain 9606
822 4RFE 1 A, C, E, H Fab heavy chain of ADCC-potent anti-HIV-1 antibody JR4 9544
823 4RFE 2 B, D, F, L Fab light chain of ADCC-potent anti-HIV-1 antibody JR4 9544
824 3OAY 1 K, L Fab 2G12, light chain 9606
825 3OAY 2 H, M Fab 2G12, heavy chain 9606
826 5KSA 3 C Bel602 alpha TRAV20*01 9606
827 5KSA 4 D Bel602 beta TRBV9*01 9606
828 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090
829 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090
830 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
831 1A3L 2 H IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090
832 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090
833 1YEJ 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090
834 4GMT 1 L, M Fab S139/1 light chain 10090
835 4GMT 2 H, I Fab S139/1 heavy chain 10090
836 5K9J 1 H 56.a.09 heavy chain 9606
837 5K9J 2 L 56.a.09 light chain 9606
838 5DS8 1 A, H Fab Hpu98 Heavy Chain 9986
839 5DS8 2 B, L Fab Hou98 Light Chain 9986
840 3ZKM 2 C, H FAB HEAVY CHAIN 9606
841 3ZKM 3 D, L FAB LIGHT CHAIN 10090
842 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN 10090
843 1FNS 2 H IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, HEAVY CHAIN 10090
844 3HNS 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
845 3HNS 2 L CS-35 Fab Light Chain Light Chain 10090
846 1KEL 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090
847 1KEL 2 H 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090
848 4DCQ 1 A 3B5H10 FAB Light Chain 10090
849 4DCQ 2 B 3B5H10 FAB Heavy Chain 10090
850 5TF1 1 H 02-CC Fab Heavy chain 9606
851 5TF1 2 L O2-CC Fab Light Chain 9606
852 3TCL 1 A, H CH04 Heavy Chain Fab 9606
853 3TCL 2 B, L CH04 Light Chain Fab 9606
854 4OJF 1 H Humanised 3D6 Fab Heavy Chain 10090
855 4OJF 2 L Humanised 3D6 Fab Light Chain 10090
856 5F7E 1 H Fab heavy chain 3BNC60 germline heavy chain 9606
857 5F7E 2 L Fab light chain 9606
858 1N0X 1 L, M IMMUNOGLOBULIN LIGHT CHAIN UNP residues 132-239 9606
859 1N0X 2 H, K IMMUNOGLOBULIN HEAVY CHAIN UNP residues 117-222 9606
860 5D7J 1 A, G M33.64 TCR Alpha Chain 9606
861 5D7J 2 B, H M33.64 TCR Beta Chain 9606
862 4PJ9 3 C TCR-alpha 9606
863 4PJ9 4 D TCR-beta 9606
864 2FAT 1 L FAB ATN-615, light chain 10090
865 2FAT 2 H FAB ATN-615, heavy chain 10090
866 1RUL 1 L immunoglobulin igg2a, light chain fab 10090
867 1RUL 2 H immunoglobulin igg2a, heavy chain fab 10090
868 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
869 1T3F 2 B Huzaf antibody heavy chain The source is engineered human constant and framework regions with CDRs from mouse 9606
870 4WCY 1 H AZ130 Heavy chain 10090
871 4WCY 2 L AZ130 Light chain 10090
872 5FHA 1 H Antibody 114 Fab heavy chain 9606
873 5FHA 2 L Antibody 114 Fab light chain 9606
874 4H88 2 H POM1 FAB CHAIN H 10090
875 4H88 3 L POM1 FAB CHAIN L 10090
876 5UMN 2 C, E Antibody C05 VPGSGW mutant, heavy chain 9606
877 5UMN 3 D, F Antibody C05, light chain 9606
878 4X7S 1 H Epididymis luminal protein 214 residues 20-241 9606
879 4X7S 2 L Ig kappa chain C region residues 23-236 9606
880 1UM6 1 L antibody 21h3, L chain 10090
881 1UM6 2 H antibody 21h3, H chain 10090
882 5DVL 1 A Ig gamma-1 chain C region UNP residues 104-330 9606
883 5U16 3 E, G MAIT T-cell receptor alpha chain 9606
884 5U16 4 F, H MAIT T-cell receptor beta chain 9606
885 5DD5 1 H ANTI-HIV ANTIBODY DH570.9 FAB HEAVY CHAIN 9544
886 5DD5 2 L ANTI-HIV ANTIBODY DH570.9 FAB HEAVY CHAIN 9544
887 3H0T 1 A Fab fragment, Light chain 9606
888 3H0T 2 B Fab fragment, Heavy chain 9606
889 5A2I 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
890 2AK1 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
891 2AK1 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
892 4X0K 1 A, H Fab fragment heavy chain 9606
893 4X0K 2 B, L Fab fragment light chain 9606
894 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
895 1S3K 2 H HU3S193 Fab fragment, heavy chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
896 5U52 1 A, B IGG1 FC unp residues 262-469 9606
897 3HNV 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
898 3HNV 2 L CS-35 Fab Light Chain Light Chain 10090
899 5E8E 1 A IGA FAB LIGHT CHAIN 9606
900 5E8E 2 B IGA FAB HEAVY CHAIN 9606
901 3LEY 1 H 6a7 Antibody Heavy Chain 10090
902 3LEY 2 L 6a7 Antibody Light Chain 10090
903 1YEI 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING DOMAIN 10090
904 1YEI 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING DOMAIN 10090
905 3QPQ 1 C, E, I, L C1068 light chain 10090
906 3QPQ 2 D, F, H, J C1068 heavy chain 10090
907 3GJF 4 K, L Antibody light chain 9606
908 3GJF 5 H, M Antibody heavy chain 9606
909 5W3P 1 L Antibody C706 Fab LIGHT CHAIN 10090
910 5W3P 2 H Antibody C706 Fab HEAVY CHAIN 10090
911 5JIK 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
912 3UJJ 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 4025 9606
913 3UJJ 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 4025 9606
914 3WBD 1 A, B single chain Fv fragment of mAb735 10090
915 2HFF 1 A, L CB2 Fab, light chain 9606
916 2HFF 2 B, H CB2 Fab, heavy chain 9606
917 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
918 4M7K 2 H 10H10 heavy chain FD, SEE REMARK 999 10090
919 1NDG 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-8 light chain 10090
920 1NDG 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-8 10090
921 5D7I 3 E, G M33.64 TCR Alpha Chain 9606
922 5D7I 4 F, H M33.64 TCR Beta Chain 9606
923 3OKD 1 A S25-39 Fab (IgG1k) light chain 10090
924 3OKD 2 B S25-39 Fab (IgG1k) heavy chain 10090
925 5FCS 1 H Diabody 9606
926 5FCS 2 L Diabody 9606
927